Senti Biosciences Inc. is a leading biotechnology company specializing in synthetic biology and gene editing. Their innovative platform harnesses the power of CRISPR technology to create next-generation therapies for various diseases, including cancer. With a team of highly skilled scientists and cutting-edge research, Senti Biosciences is poised to revolutionize the field of precision medicine.
